CD4 and acute respiratory distress syndrome: In addition, we previously reported that T-cell function was preserved, including IFN-γ+ CD4+ T cells, IFN-γ+ CD8+ T cells, and TNFα+ CD4+ T cells, in patients with ARDs who received heterologous CoronaVac/ChAdOx1 as a primary series vaccine [16].